Product Details
| Product Name:
Beraprost sodium |
CAS No.:
88475-69-8 |
| Min. Order:
1KG |
Purity:
99% |
| Supply Ability:
100KG |
Release date:
2019/07/14 |
JD 607 108
| Product Name: |
Beraprost sodium |
| Synonyms: |
Sodium 2,3,3a-8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-ynyl)-1H-cyclopenta[b]benzofuran-5-butanoate;Befraprost;Unii-15K99vdu5f;dl-4-[(1R,2R,3aS,8bS)-2,3,3a,8b-Tetrahydro-2-hydroxy-[(3S,4RS)-3-hydroxy-4-Methyl-oct-6-yne-(E)-1-enyl]-5-cyclopenta[b]benzofuranyl]butanoic Acid SodiuM;Berasus;Careload;beraprostsodium;ML 1129 |
| CAS: |
88475-69-8 |
| MF: |
C24H29NaO5 |
| MW: |
420.47 |
| EINECS: |
|
| Product Categories: |
Prostaglandin;Chiral Reagents;Prostaglandins;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals |
| Mol File: |
88475-69-8.mol |
 |
| |
| Beraprost sodium Chemical Properties |
| Melting point |
204-206°C |
| storage temp. |
Amber Vial, -20?C Freezer, Under Inert Atmosphere |
| form |
powder |
| color |
white to beige |
| CAS DataBase Reference |
88475-69-8(CAS DataBase Reference) |
| |
| Beraprost sodium Usage And Synthesis |
| Description |
Beraprost sodium is a new, orally active antithrombotic epoprostenol analog introduced as a treatment for peripheral vascular disease, including Raynaud's syndrome and Buerger's disease. The antiplatelet activity may be due to its elevation of cyclic AMP in platelets which is achieved by activating adenylate cyclase in the platelet membrane, followed by the inhibition ofCa++- influx and thromboxane A2 formation. |
Company Profile Introduction
Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals.
Mainly deals in the sales of:
Pharmaceutical intermediates
OLED intermediates:
Pharmaceutical intermediates;
OLED intermediates;
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-11-18 |
|
|
$5.00
|
|
Wuhan JiyunZen Tech Co., Ltd.
|
2026-04-10 |
|
|
|
|
Honest Joy Holdings Limited
|
2022-01-14 |